These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 20956352

  • 1. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
    Oteng B, Marra F, Lynd LD, Ogilvie G, Patrick D, Marra CA.
    Sex Transm Infect; 2011 Feb; 87(1):52-7. PubMed ID: 20956352
    [Abstract] [Full Text] [Related]

  • 2. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M.
    Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [Abstract] [Full Text] [Related]

  • 3. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?
    Juraskova I, Bari RA, O'Brien MT, McCaffery KJ.
    Womens Health Issues; 2011 Nov; 21(1):71-9. PubMed ID: 21185992
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM, Reynolds SM, Jacobson RM.
    Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
    [Abstract] [Full Text] [Related]

  • 5. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P, Jit M.
    Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
    [Abstract] [Full Text] [Related]

  • 6. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
    Thomas TL.
    Pediatr Nurs; 2008 Sep; 34(5):429-31. PubMed ID: 19051848
    [Abstract] [Full Text] [Related]

  • 7. Human papillomavirus, cervical cancer, and the vaccines.
    Tovar JM, Bazaldua OV, Vargas L, Reile E.
    Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
    Chen MK, Hung HF, Duffy S, Yen AM, Chen HH.
    J Eval Clin Pract; 2011 Dec; 17(6):1050-8. PubMed ID: 21679279
    [Abstract] [Full Text] [Related]

  • 9. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
    Tota J, Mahmud SM, Ferenczy A, Coutlée F, Franco EL.
    Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V, Murtagh J.
    Issues Emerg Health Technol; 2007 Dec; (109):1-8. PubMed ID: 18062141
    [Abstract] [Full Text] [Related]

  • 11. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study.
    Brisson M, Laprise JF, Drolet M, Van de Velde N, Franco EL, Kliewer EV, Ogilvie G, Deeks SL, Boily MC.
    Vaccine; 2013 Aug 20; 31(37):3863-71. PubMed ID: 23830974
    [Abstract] [Full Text] [Related]

  • 12. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P, Henrion R, Blanc B, Girard M, Sancho-Garnier H.
    Bull Acad Natl Med; 2007 Dec 20; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [Abstract] [Full Text] [Related]

  • 13. Intention to obtain human papillomavirus vaccination among taiwanese undergraduate women.
    Hsu YY, Fetzer SJ, Hsu KF, Chang YY, Huang CP, Chou CY.
    Sex Transm Dis; 2009 Nov 20; 36(11):686-92. PubMed ID: 19652629
    [Abstract] [Full Text] [Related]

  • 14. Quadrivalent human papillomavirus vaccine.
    Barr E, Tamms G.
    Clin Infect Dis; 2007 Sep 01; 45(5):609-7. PubMed ID: 17682997
    [Abstract] [Full Text] [Related]

  • 15. The acceptability of human papillomavirus (HPV) vaccination among women with physical disabilities.
    Yen CF, Chen SF, Lin LP, Hsu SW, Chang MJ, Wu CL, Lin JD.
    Res Dev Disabil; 2011 Sep 01; 32(5):2020-6. PubMed ID: 21571498
    [Abstract] [Full Text] [Related]

  • 16. Start early to prevent genital HPV infection-and cervical cancer.
    Heavey E.
    Nursing; 2008 May 01; 38(5):62-3. PubMed ID: 18431214
    [No Abstract] [Full Text] [Related]

  • 17. Reducing the health burden of HPV infection through vaccination.
    Soper D.
    Infect Dis Obstet Gynecol; 2006 May 01; 2006 Suppl():83084. PubMed ID: 16967913
    [Abstract] [Full Text] [Related]

  • 18. Decreasing risk: impact of HPV vaccination on outcomes.
    Hymel PA.
    Am J Manag Care; 2006 Dec 01; 12(17 Suppl):S473-83. PubMed ID: 17203991
    [Abstract] [Full Text] [Related]

  • 19. [HPV-infection].
    Schmidt-Petruschkat S.
    MMW Fortschr Med; 2007 Mar 22; 149(12):29-31. PubMed ID: 17674887
    [Abstract] [Full Text] [Related]

  • 20. Human papillomavirus vaccines and vaccine implementation.
    de Sanjosé S, Alemany L, Castellsagué X, Bosch FX.
    Womens Health (Lond); 2008 Nov 22; 4(6):595-604. PubMed ID: 19072462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.